Literature DB >> 27409487

Type 1 Choroidal Neovascularization Lesion Size: Indocyanine Green Angiography Versus Optical Coherence Tomography Angiography.

Eliana Costanzo1, Alexandra Miere2, Giuseppe Querques3, Vittorio Capuano2, Camille Jung2, Eric H Souied2.   

Abstract

PURPOSE: To evaluate the size of type 1 choroidal neovascularization (CNV) in neovascular AMD by optical coherence tomography angiography (OCTA) and to compare with indocyanine green angiography (ICGA).
METHODS: Patients diagnosed type 1 CNV underwent multimodal imaging by fluorescein angiography (FA), ICGA, spectral-domain (SD)-OCT, and OCTA. Lesion size was measured both on OCTA at the choriocapillaris level with "select area" and "vessel area" functions, incorporated in AngioVue software and on ICGA at intermediate and late phases, by two masked independent readers.
RESULTS: Nineteen eyes of 17 patients (mean age 80.6 ± 8.36) were included in the analysis. Mean visual acuity was 0.2 logMAR. All OCTA revealed a high flow neovascular network in the choriocapillaris segmentation. On OCTA, interclass correlation between readers 1 and 2 was 0.96 (95% confidence interval [CI] 0.94-0.99) for select area and 0.97 (95% CI 0.96-0.99) for vessel area. The difference between lesion size in OCTA versus ICGA was detected in all eyes and it was statistically significant for both readers (P < 0.05).
CONCLUSIONS: Optical coherence tomography angiography provides both quantitative and qualitative information on type 1 CNV and appears as a new reproducible way to evaluate CNV area and vessels area. Type 1 CNV lesion size in the choriocapillaris segmentation of OCTA and ICGA intermediate and late phases revealed that the OCTA size is significantly smaller than the ICGA size. This supports the idea that OCTA could be considered for evaluation of the neovascular lesion and for evaluation of therapeutic responses.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27409487     DOI: 10.1167/iovs.15-18830

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  17 in total

1.  [Statement of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the German Retina Society (RG): OCT angiography in Germany : Presentation, nomenclature and future plans. Situation January 2017].

Authors: 
Journal:  Ophthalmologe       Date:  2017-05       Impact factor: 1.059

2.  Optical coherence tomography angiography of types 1 and 2 choroidal neovascularization in age-related macular degeneration during anti-VEGF therapy: evaluation of a new quantitative method.

Authors:  Henrik Faatz; Marie-Louise Farecki; Kai Rothaus; Frederic Gunnemann; Matthias Gutfleisch; Albrecht Lommatzsch; Daniel Pauleikhoff
Journal:  Eye (Lond)       Date:  2019-04-10       Impact factor: 3.775

3.  The use of optical coherence tomography angiography for detecting choroidal neovascularization, compared to standard multimodal imaging.

Authors:  T Soomro; J Talks
Journal:  Eye (Lond)       Date:  2018-03-30       Impact factor: 3.775

Review 4.  Optical coherence tomography angiography: A comprehensive review of current methods and clinical applications.

Authors:  Amir H Kashani; Chieh-Li Chen; Jin K Gahm; Fang Zheng; Grace M Richter; Philip J Rosenfeld; Yonggang Shi; Ruikang K Wang
Journal:  Prog Retin Eye Res       Date:  2017-07-29       Impact factor: 21.198

5.  Quantitative Optical Coherence Tomography Angiography Biomarkers in a Treat-and-Extend Dosing Regimen in Neovascular Age-Related Macular Degeneration.

Authors:  Diogo Cabral; Florence Coscas; Telmo Pereira; Catherine Français; Carlos Geraldes; Rita Laiginhas; Catarina Rodrigues; Alexis Khorrami Kashi; Vanda Nogueira; Manuel Falcão; Ana Luísa Papoila; Marco Lupidi; Gabriel Coscas; Salomon Yves Cohen; Eric Souied
Journal:  Transl Vis Sci Technol       Date:  2020-02-14       Impact factor: 3.283

6.  Comparison between optical coherence tomography angiography and immunolabeling for evaluation of laser-induced choroidal neovascularization.

Authors:  Kazuki Nakagawa; Haruhiko Yamada; Hidetsugu Mori; Keiko Toyama; Kanji Takahashi
Journal:  PLoS One       Date:  2018-08-09       Impact factor: 3.240

Review 7.  An overview of the clinical applications of optical coherence tomography angiography.

Authors:  A C S Tan; G S Tan; A K Denniston; P A Keane; M Ang; D Milea; U Chakravarthy; C M G Cheung
Journal:  Eye (Lond)       Date:  2017-09-08       Impact factor: 3.775

8.  Comparison of Neovascular Lesion Area Measurements From Different Swept-Source OCT Angiographic Scan Patterns in Age-Related Macular Degeneration.

Authors:  Fang Zheng; Qinqin Zhang; Elie H Motulsky; João Rafael de Oliveira Dias; Chieh-Li Chen; Zhongdi Chu; Andrew R Miller; William Feuer; Giovanni Gregori; Sophie Kubach; Mary K Durbin; Ruikang K Wang; Philip J Rosenfeld
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-10-01       Impact factor: 4.799

9.  Quantitative optical coherence tomography angiography biomarkers for neovascular age-related macular degeneration in remission.

Authors:  Florence Coscas; Diogo Cabral; Telmo Pereira; Carlos Geraldes; Hemaxi Narotamo; Alexandra Miere; Marco Lupidi; Alexandre Sellam; Ana Papoila; Gabriel Coscas; Eric Souied
Journal:  PLoS One       Date:  2018-10-09       Impact factor: 3.240

10.  Diurnal variation of choriocapillaris vessel flow density in normal subjects measured using optical coherence tomography angiography.

Authors:  Salman Sarwar; Muhammad Hassan; Mohamed K Soliman; Muhammad Sohail Halim; Mohammad Ali Sadiq; Rubbia Afridi; Aniruddha Agarwal; Diana V Do; Quan Dong Nguyen; Yasir J Sepah
Journal:  Int J Retina Vitreous       Date:  2018-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.